News

Here you'll find the latest press releases issued by Rejuveron and its subsidiary companies. Scroll down to discover more stories about our science, our business and our people. 

12.12.2021
Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye
18.11.2021
Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York
11.10.2021
Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging
26.01.2021
Endogena completes 8 million financing and extends Series A round
31.12.2020
Rejuveron has moved to its new Incubator space in the Bio-Technopark in Schlieren-Zürich
21.01.2022
Our sponsored feature in nature describes our vision to make therapies happen
03.11.2021
Women in Biotech - What does it take to increase gender equality in biotech?
20.07.2021
Make your research work: scientific freedom with sustainable support
19.07.2021
Make your future at Rejuveron: from valves and pipes to leading longevity discovery
14.12.2020
Rejuveron Senescence Therapeutics: Bringing senescent cells out of hiding